developed an AAV serotype 2 vector expressing the human CLN2 cDNA (AAV2CUhCLN2) and administered the vector in the CNS of 10 children with late infantile NCL (LINCL).262. This evidence concerns the gene TPP1 and late infantile neuronal ceroid lipofuscinosis.